Janux Therapeutics, Inc.

Q1 2024 13F Holders

Symbol
JANX
CUSIP
47103J105
Type
Equity
Class
COM
Num filings
132
Total reported value, excl. options
$1.62 B
Manager Report Date Value ($000) Shares Option Type